Sequence
ENSP00000269305 is from the Homo sapiens 63_37 genome.
The highlighted portions of sequence are where there is 75% agreement between all disorder pedictors.
>ENSP00000269305
MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPAAPAPAPSWPLSSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKEPGGSRAHSSHLKSKKGQSTSRHKKLMFKTEGPDSD
View in source genome browser
UniProt Gene descriptions
| UniProt |
Gene Name |
Gene Description |
| H2QC53 |
ENSG00000141510 |
Cellular tumor antigen p53 |
| P04637 |
TP53 |
Tumor suppressor p53 |
Disordered Regions
75% of predictor's agree:
| Start |
End |
| 1 |
22 |
| 26 |
27 |
| 30 |
31 |
| 33 |
97 |
| 281 |
329 |
| 343 |
393 |
By predictor:
| Predictor |
Start |
End |
| VLXT |
1 |
18 |
| VSL2b |
1 |
107 |
| PrDOS |
1 |
15 |
| PV2 |
1 |
107 |
| IUPred-S |
1 |
16 |
| IUPred-L |
1 |
23 |
| Espritz-N |
1 |
132 |
| Espritz-X |
1 |
31 |
| Espritz-D |
1 |
65 |
| IUPred-S |
21 |
21 |
| IUPred-L |
25 |
27 |
| PrDOS |
27 |
99 |
| IUPred-L |
30 |
31 |
| IUPred-L |
33 |
97 |
| VLXT |
34 |
99 |
| IUPred-S |
37 |
40 |
| IUPred-S |
42 |
87 |
| Espritz-X |
50 |
96 |
| IUPred-S |
89 |
93 |
| PrDOS |
119 |
122 |
| Espritz-N |
139 |
156 |
| PV2 |
145 |
148 |
| PV2 |
151 |
197 |
| VLXT |
152 |
165 |
| IUPred-L |
156 |
161 |
| IUPred-S |
157 |
162 |
| Espritz-N |
163 |
169 |
| VSL2b |
165 |
166 |
| VSL2b |
168 |
189 |
| IUPred-L |
174 |
176 |
| PrDOS |
178 |
194 |
| Espritz-N |
179 |
190 |
| IUPred-S |
183 |
185 |
| IUPred-S |
187 |
187 |
| IUPred-L |
187 |
187 |
| IUPred-L |
189 |
189 |
| IUPred-L |
193 |
193 |
| PrDOS |
198 |
202 |
| PV2 |
215 |
220 |
| IUPred-L |
216 |
217 |
| Espritz-N |
220 |
228 |
| VLXT |
221 |
221 |
| VSL2b |
222 |
224 |
| PV2 |
222 |
225 |
| PrDOS |
223 |
228 |
| PV2 |
228 |
228 |
| Espritz-N |
240 |
249 |
| PrDOS |
243 |
248 |
| PV2 |
243 |
243 |
| VSL2b |
260 |
393 |
| Espritz-N |
262 |
263 |
| Espritz-X |
262 |
393 |
| PV2 |
263 |
265 |
| Espritz-N |
266 |
266 |
| PV2 |
268 |
268 |
| PV2 |
270 |
332 |
| IUPred-L |
277 |
277 |
| Espritz-N |
277 |
393 |
| PrDOS |
279 |
326 |
| VLXT |
280 |
317 |
| IUPred-L |
281 |
329 |
| IUPred-S |
285 |
328 |
| VLXT |
326 |
329 |
| PV2 |
336 |
336 |
| PV2 |
338 |
340 |
| IUPred-L |
341 |
341 |
| VLXT |
342 |
393 |
| PV2 |
343 |
393 |
| IUPred-L |
343 |
393 |
| Espritz-D |
346 |
393 |
| PrDOS |
350 |
393 |
| IUPred-S |
351 |
393 |
SCOP Domain Regions
Hits with strong support:
| Superfamily Name |
SFam ID |
SFam E-value |
Family Name |
Fam ID |
Fam E-value |
Region |
| p53 tetramerization domain |
47719 |
0.0000000000131 |
|
|
|
319-357 |
| p53-like transcription factors |
49417 |
1.16e-90 |
p53 DNA-binding domain-like |
81314 |
0.00000000408 |
97-287 |
Hits with weaker support:
No weak SCOP hits found.
Pfam Domain Regions
| Type |
Clan |
Family |
Name |
Description |
E-value |
Bitscore |
Start |
End |
| Motif |
No Clan |
PF08563.6 |
P53_TAD |
P53 transactivation motif |
0.00000000022 |
39.3 |
5 |
29 |
| Domain |
CL0073 |
PF00870.13 |
P53 |
P53 DNA-binding domain |
1.2e-109 |
364.4 |
95 |
289 |
| Motif |
No Clan |
PF07710.6 |
P53_tetramer |
P53 tetramerisation motif |
1e-19 |
69.3 |
318 |
359 |
Post Translational Modification Sites
| Locus |
Amino Acid |
Disordered |
PTM Type |
Sequence Context |
| 6 |
S |
Yes |
PHOSPHORYLATION |
__MEEPQsDPsVEPP |
| 9 |
S |
Yes |
PHOSPHORYLATION |
EEPQsDPsVEPPLsQ |
| 15 |
S |
Yes |
PHOSPHORYLATION |
PsVEPPLsQEtFsDL |
| 18 |
T |
Yes |
PHOSPHORYLATION |
EPPLsQEtFsDLWKL |
| 20 |
S |
Yes |
PHOSPHORYLATION |
PLsQEtFsDLWKLLP |
| 33 |
S |
Yes |
PHOSPHORYLATION |
LPENNVLsPLPsQAM |
| 37 |
S |
Yes |
PHOSPHORYLATION |
NVLsPLPsQAMDDLM |
| 46 |
S |
Yes |
PHOSPHORYLATION |
AMDDLMLsPDDIEQW |
| 55 |
T |
Yes |
PHOSPHORYLATION |
DDIEQWFtEDPGPDE |
| 81 |
T |
Yes |
PHOSPHORYLATION |
APAPAAPtPAAPAPA |
| 99 |
S |
Yes |
PHOSPHORYLATION |
PLSSSVPsQkTYQGs |
| 101 |
K |
Yes |
UBIQUITYLATION |
SSSVPsQkTYQGsYG |
| 106 |
S |
Yes |
PHOSPHORYLATION |
sQkTYQGsYGFrLGF |
| 110 |
R |
Yes |
MONO-METHYLATION |
YQGsYGFrLGFLhSG |
| 115 |
H |
Yes |
MONO-METHYLATION |
GFrLGFLhSGTAkSV |
| 120 |
K |
Yes |
ACETYLATION |
FLhSGTAkSVTCTyS |
| 120 |
K |
Yes |
UBIQUITYLATION |
FLhSGTAkSVTCTyS |
| 126 |
Y |
Yes |
PHOSPHORYLATION |
AkSVTCTySPALNkM |
| 132 |
K |
Yes |
UBIQUITYLATION |
TySPALNkMFCQLAk |
| 139 |
K |
Yes |
UBIQUITYLATION |
kMFCQLAkTCPVQLW |
| 149 |
S |
Yes |
GLYCOSYLATION |
PVQLWVDstPPPGtR |
| 149 |
S |
Yes |
PHOSPHORYLATION |
PVQLWVDstPPPGtR |
| 150 |
T |
Yes |
PHOSPHORYLATION |
VQLWVDstPPPGtRV |
| 155 |
T |
Yes |
PHOSPHORYLATION |
DstPPPGtRVRAMAI |
| 164 |
K |
Yes |
UBIQUITYLATION |
VRAMAIYkQSQHMTE |
| 164 |
K |
Yes |
ACETYLATION |
VRAMAIYkQSQHMTE |
| 183 |
S |
Yes |
PHOSPHORYLATION |
CPHHERCsDSDGLAP |
| 209 |
R |
No |
MONO-METHYLATION |
RVEYLDDrNtFrHsV |
| 211 |
T |
Yes |
PHOSPHORYLATION |
EYLDDrNtFrHsVVV |
| 213 |
R |
No |
MONO-METHYLATION |
LDDrNtFrHsVVVPy |
| 215 |
S |
Yes |
PHOSPHORYLATION |
DrNtFrHsVVVPyEP |
| 220 |
Y |
Yes |
PHOSPHORYLATION |
rHsVVVPyEPPEVGS |
| 269 |
S |
Yes |
PHOSPHORYLATION |
GNLLGRNsFEVRVCA |
| 284 |
T |
Yes |
PHOSPHORYLATION |
CPGRDRRtEEENLRk |
| 291 |
K |
Yes |
UBIQUITYLATION |
tEEENLRkkGEPHHE |
| 292 |
K |
Yes |
UBIQUITYLATION |
EEENLRkkGEPHHEL |
| 292 |
K |
Yes |
ACETYLATION |
EEENLRkkGEPHHEL |
| 305 |
K |
Yes |
ACETYLATION |
ELPPGSTkRALPNNt |
| 305 |
K |
Yes |
UBIQUITYLATION |
ELPPGSTkRALPNNt |
| 312 |
T |
Yes |
PHOSPHORYLATION |
kRALPNNtsssPQPk |
| 313 |
S |
Yes |
PHOSPHORYLATION |
RALPNNtsssPQPkk |
| 314 |
S |
Yes |
PHOSPHORYLATION |
ALPNNtsssPQPkkk |
| 315 |
S |
Yes |
PHOSPHORYLATION |
LPNNtsssPQPkkkP |
| 319 |
K |
Yes |
ACETYLATION |
tsssPQPkkkPLDGE |
| 319 |
K |
Yes |
UBIQUITYLATION |
tsssPQPkkkPLDGE |
| 320 |
K |
Yes |
UBIQUITYLATION |
sssPQPkkkPLDGEy |
| 320 |
K |
Yes |
ACETYLATION |
sssPQPkkkPLDGEy |
| 321 |
K |
Yes |
UBIQUITYLATION |
ssPQPkkkPLDGEyF |
| 327 |
Y |
Yes |
PHOSPHORYLATION |
kkPLDGEyFTLQIrG |
| 333 |
R |
Yes |
METHYLATION |
EyFTLQIrGrErFEM |
| 335 |
R |
Yes |
DI-METHYLATION |
FTLQIrGrErFEMFR |
| 337 |
R |
Yes |
DI-METHYLATION |
LQIrGrErFEMFREL |
| 351 |
K |
Yes |
UBIQUITYLATION |
LNEALELkDAQAGkE |
| 357 |
K |
Yes |
UBIQUITYLATION |
LkDAQAGkEPGGsRA |
| 362 |
S |
Yes |
PHOSPHORYLATION |
AGkEPGGsRAHsSHL |
| 366 |
S |
Yes |
PHOSPHORYLATION |
PGGsRAHsSHLkskk |
| 370 |
K |
Yes |
UBIQUITYLATION |
RAHsSHLkskkGQst |
| 370 |
K |
Yes |
MONO-METHYLATION |
RAHsSHLkskkGQst |
| 370 |
K |
Yes |
METHYLATION |
RAHsSHLkskkGQst |
| 370 |
K |
Yes |
DI-METHYLATION |
RAHsSHLkskkGQst |
| 370 |
K |
Yes |
ACETYLATION |
RAHsSHLkskkGQst |
| 370 |
K |
Yes |
TRI-METHYLATION |
RAHsSHLkskkGQst |
| 371 |
S |
Yes |
PHOSPHORYLATION |
AHsSHLkskkGQsts |
| 372 |
K |
Yes |
UBIQUITYLATION |
HsSHLkskkGQstsR |
| 372 |
K |
Yes |
METHYLATION |
HsSHLkskkGQstsR |
| 372 |
K |
Yes |
MONO-METHYLATION |
HsSHLkskkGQstsR |
| 372 |
K |
Yes |
ACETYLATION |
HsSHLkskkGQstsR |
| 373 |
K |
Yes |
DI-METHYLATION |
sSHLkskkGQstsRH |
| 373 |
K |
Yes |
ACETYLATION |
sSHLkskkGQstsRH |
| 373 |
K |
Yes |
MONO-METHYLATION |
sSHLkskkGQstsRH |
| 373 |
K |
Yes |
UBIQUITYLATION |
sSHLkskkGQstsRH |
| 376 |
S |
Yes |
PHOSPHORYLATION |
LkskkGQstsRHkkL |
| 377 |
T |
Yes |
PHOSPHORYLATION |
kskkGQstsRHkkLM |
| 378 |
S |
Yes |
PHOSPHORYLATION |
skkGQstsRHkkLMF |
| 381 |
K |
Yes |
UBIQUITYLATION |
GQstsRHkkLMFktE |
| 381 |
K |
Yes |
ACETYLATION |
GQstsRHkkLMFktE |
| 382 |
K |
Yes |
DI-METHYLATION |
QstsRHkkLMFktEG |
| 382 |
K |
Yes |
ACETYLATION |
QstsRHkkLMFktEG |
| 382 |
K |
Yes |
MONO-METHYLATION |
QstsRHkkLMFktEG |
| 382 |
K |
Yes |
UBIQUITYLATION |
QstsRHkkLMFktEG |
| 386 |
K |
Yes |
DI-METHYLATION |
RHkkLMFktEGPDsD |
| 386 |
K |
Yes |
SUMOYLATION |
RHkkLMFktEGPDsD |
| 386 |
K |
Yes |
ACETYLATION |
RHkkLMFktEGPDsD |
| 386 |
K |
Yes |
UBIQUITYLATION |
RHkkLMFktEGPDsD |
| 386 |
K |
Yes |
MONO-METHYLATION |
RHkkLMFktEGPDsD |
| 387 |
T |
Yes |
PHOSPHORYLATION |
HkkLMFktEGPDsD_ |
| 392 |
S |
Yes |
PHOSPHORYLATION |
FktEGPDsD______ |